HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kwangmeyung Kim Selected Research

Neoplasm Antigens (Tumor Antigens)

6/2021Theragnostic Glycol Chitosan-Conjugated Gold Nanoparticles for Photoacoustic Imaging of Regional Lymph Nodes and Delivering Tumor Antigen to Lymph Nodes.
1/2018Engineering nanoparticle strategies for effective cancer immunotherapy.
10/2016Engineered Human Ferritin Nanoparticles for Direct Delivery of Tumor Antigens to Lymph Node and Cancer Immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kwangmeyung Kim Research Topics

Disease

204Neoplasms (Cancer)
04/2024 - 03/2006
11Breast Neoplasms (Breast Cancer)
12/2020 - 05/2008
9Thrombosis (Thrombus)
01/2021 - 06/2007
9Rheumatoid Arthritis
06/2019 - 11/2008
8Inflammation (Inflammations)
04/2022 - 10/2006
6Atherosclerosis
01/2020 - 03/2010
6Osteoarthritis
06/2019 - 09/2008
6Melanoma (Melanoma, Malignant)
12/2013 - 03/2006
5Stroke (Strokes)
01/2021 - 05/2013
5Colonic Neoplasms (Colon Cancer)
12/2015 - 12/2009
5Experimental Arthritis
10/2015 - 12/2010
4Neoplasm Metastasis (Metastasis)
07/2022 - 06/2007
4Ischemia
01/2021 - 09/2013
4Hyperthermia
07/2020 - 05/2013
4Arthritis (Polyarthritis)
06/2019 - 12/2011
3Cardiotoxicity
03/2023 - 12/2010
3Pancreatic Neoplasms (Pancreatic Cancer)
11/2022 - 04/2022
3Hemorrhage
01/2017 - 12/2014

Drug/Important Bio-Agent (IBA)

51glycol-chitosanIBA
10/2023 - 10/2007
33Peptides (Polypeptides)IBA
03/2024 - 04/2008
25Small Interfering RNA (siRNA)IBA
11/2022 - 12/2009
24Doxorubicin (Adriamycin)FDA LinkGeneric
03/2024 - 02/2010
21GoldIBA
01/2024 - 12/2010
20Hyaluronic Acid (Hyaluronan)IBA
11/2022 - 01/2010
19Matrix Metalloproteinases (MMPs)IBA
01/2016 - 09/2008
17ProdrugsIBA
03/2024 - 02/2015
15Cathepsin BIBA
03/2024 - 01/2012
14Proteins (Proteins, Gene)FDA Link
03/2024 - 06/2007
14Therapeutic UsesIBA
10/2023 - 05/2008
14Drug CarriersIBA
01/2023 - 04/2008
14Coloring Agents (Dyes)IBA
07/2020 - 12/2009
12Immune Checkpoint InhibitorsIBA
03/2024 - 04/2020
11LigandsIBA
12/2017 - 11/2008
10Photosensitizing Agents (Photosensitizers)IBA
04/2023 - 05/2009
10MicellesIBA
03/2023 - 11/2007
9Liposomes (Liposome)IBA
03/2024 - 12/2009
9PolymersIBA
03/2023 - 10/2007
8Antineoplastic Agents (Antineoplastics)IBA
06/2023 - 05/2009
81-phenyl-3,3-dimethyltriazene (PDT)IBA
04/2023 - 04/2011
8Poloxamer (Poloxamer 407)IBA
10/2021 - 05/2010
8CY5.5 cyanine dyeIBA
07/2020 - 10/2007
7Heparin (Liquaemin)FDA LinkGeneric
12/2014 - 06/2007
6AlbuminsIBA
01/2023 - 04/2011
6Paclitaxel (Taxol)FDA LinkGeneric
03/2022 - 03/2006
6Contrast MediaIBA
01/2019 - 01/2014
6IntegrinsIBA
01/2017 - 04/2008
6ChitosanIBA
11/2015 - 04/2010
5AntigensIBA
04/2023 - 02/2015
5CytokinesIBA
04/2022 - 02/2014
5EnzymesIBA
04/2020 - 12/2009
5AzidesIBA
01/2020 - 03/2014
5Peptide Hydrolases (Proteases)FDA Link
06/2019 - 03/2010
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2017 - 12/2013
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2015 - 11/2008
5Docetaxel (Taxotere)FDA Link
07/2014 - 10/2011
4Silicon Dioxide (Silica)FDA LinkGeneric
01/2024 - 10/2011
4Caspase 3 (Caspase-3)IBA
04/2022 - 02/2015
4Dextran SulfateIBA
04/2022 - 01/2014
4Human Serum AlbuminFDA LinkGeneric
03/2022 - 04/2011
4Oxygen (Dioxygen)IBA
01/2022 - 01/2018
4Fluorescent Dyes (Fluorescent Probes)IBA
01/2020 - 07/2014
4Tissue Plasminogen Activator (Alteplase)FDA Link
01/2017 - 05/2013
42- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
11/2011 - 05/2008
3CaspasesIBA
03/2024 - 02/2011
3maleimideIBA
01/2023 - 12/2019
3CollagenIBA
11/2022 - 10/2017
3HydrogelsIBA
09/2022 - 10/2006
3Reactive Oxygen Species (Oxygen Radicals)IBA
04/2022 - 10/2016
3phenylalanyl-arginyl-arginineIBA
10/2021 - 12/2020
3Neoplasm Antigens (Tumor Antigens)IBA
06/2021 - 10/2016
3ErbB Receptors (EGF Receptor)IBA
12/2020 - 12/2013
3ferric oxide (iron oxide)IBA
07/2020 - 04/2011
3Singlet OxygenIBA
12/2019 - 04/2011
3Polysaccharides (Glycans)IBA
01/2017 - 11/2016
3AcidsIBA
01/2017 - 06/2010
3CopperIBA
10/2016 - 11/2012
3Ferritins (Ferritin)IBA
10/2016 - 02/2011
3DisulfidesIBA
11/2014 - 10/2011
3CeramidesIBA
01/2014 - 10/2011
3Ethylene Glycol (Monoethylene Glycol)IBA
06/2013 - 02/2010
3protoporphyrin IXIBA
06/2011 - 05/2009
3poly(beta-amino ester)IBA
06/2010 - 11/2007
3monomethoxypolyethylene glycol (MPEG)IBA
06/2010 - 11/2007
2Monoclonal AntibodiesIBA
03/2024 - 12/2013
2Glucose (Dextrose)FDA LinkGeneric
03/2023 - 01/2017
2snake venom protein C activatorIBA
01/2023 - 01/2023
2Proteolysis Targeting ChimeraIBA
01/2023 - 01/2023
2Serum AlbuminIBA
01/2023 - 12/2019
2monomethyl auristatin EIBA
10/2022 - 04/2022

Therapy/Procedure

111Therapeutics
03/2024 - 11/2007
21Immunotherapy
04/2024 - 02/2015
17Precision Medicine
05/2021 - 04/2011
16Intravenous Injections
10/2022 - 10/2011
14Photochemotherapy (Photodynamic Therapy)
04/2023 - 08/2010
13Drug Therapy (Chemotherapy)
11/2022 - 12/2010
8Intravenous Administration
02/2016 - 06/2007
7Lasers (Laser)
01/2024 - 04/2011
7Photothermal Therapy
01/2024 - 12/2010
3RNAi Therapeutics
11/2022 - 08/2014
3Microbubbles
10/2020 - 07/2015